Company / FCF Margin
Neogen FCF Margin History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-5.2%
FY2024
5-year range
-8.2% / 8.3%
FY2020-FY2024
Trend
+37.1%
vs FY2023
Sector context
#122 of 139
Health Care
What the data says
Neogen's fcf margin of -5.2% is lower than 88% of companies in the Health Care sector (FY2024). FCF Margin returned to growth in FY2024 after 4 years of decline, reaching -5.2%.
Based on SEC 10-K filings.
-5.2% in FY2024 with a 5-year CAGR of -20.0%.
Declined from -3.0% to -5.2% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -13.5pp
- 5-Year Change
- -20.0pp
- 10-Year Change
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 139This company -5.2% Sector average -217.0%
▼
+97.6% above sector average
Key checks
Key Insights
- In FY2024, fcf margin increased 37.1% year-over-year.
- Currently 211.8pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2019.
- Lowest fcf margin in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -5.2% | +37.1% |
| FY2023 | -8.2% | -173.8% |
| FY2022 | -3.0% | -136.4% |
| FY2021 | 8.3% | -28.8% |
| FY2020 | 11.6% | -21.4% |
| FY2019 | 14.8% | +24.5% |
| FY2018 | 11.9% | -2.0% |
| FY2017 | 12.1% | -5.0% |
| FY2016 | 12.8% | +94.1% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026